Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Falling Comet

4764.0000 -108.00 (-2.22%)

NSE Aug 08, 2025 15:31 PM

26.02% Fall from 52W High

Volume: 45,812

Alkem Laboratories Ltd.

10 Aug 2023

4764.00

-2.22%

Alkem Labs (SELL): International sales fuel growth; margin recovery positive

Sell: Alkem Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q1 revenue/EBITDA a beat as international business outperformed; adj. PAT growth in line with consensus at 65% QoQ

Alkem Laboratories L.. has an average target of 5278.50 from 2 brokers.